Two-dimensional gel electrophoresis (2-D GE) is a key tool for comparative proteomics research. With its ability to separate complex protein mixtures with high resolution, 2-D GE is a technique commonly employed for protein profiling studies. Significant improvements have been made in 2-D GE technology with the development of two-dimensional fluorescence difference gel electrophoresis (2-D DIGE), where proteins are first labelled with one of three spectrally resolvable fluorescent cyanine dyes before being separated over first and second dimensions according to their charge and size, respectively. When used in conjunction with automated analysis packages, this multiplexing approach can accurately and reproducibly quantify protein expression for control and experimental groups. Differentially expressed proteins can be subsequently identified by mass spectrometric methods. Here, we describe the successful application and optimisation of 2-D DIGE technology for human postmortem brain studies. This technology, especially when coupled with other functional genomics approaches, such as transcriptomics and metabolomics studies, will enhance our current understanding of human disease and lead to new therapeutic and diagnostic possibilities.
Introduction to two-dimensional gel electrophoresis (2-D GE)
Proteomics refers to a large-scale analysis of the protein complement of a given tissue or cell, and is best coupled with other functional genomics approaches (-transcriptomics and metabolomics) in order to provide a systems-based insight into how genes act and interact. Although proteomics approaches lag behind with respect to their global coverage of the entire protein complement, new technologies are being developed and improved at a staggering pace.
2-D GE is a powerful technique capable of resolving several thousand proteins based on their charge in the first dimension, and size in the second. Since the mid-1970s, when the technique was first described, 1 2-D GE technology has been substantially advanced. A fundamental improvement was the development of 2-D fluorescent difference gel electrophoresis (2-D DIGE). 2 2-D DIGE allows for the detection and quantification of differences between two samples resolved on the same gel, thus avoiding the pitfalls of inter-gel variability associated with conventional 2-D GE. The 2-D DIGE technique requires pre-electrophoretic labelling of samples with one of three spectrally distinct fluorescent CyDyes; cyanine 3 (Cy3), cyanine 5 (Cy5) and cyanine 2 (Cy2). The labelled samples are then pooled and resolved over a first and second dimension to separate proteins according to charge and size, respectively, before being individually scanned at appropriate fluorescent wavelengths. Following the introduction of 2-D DIGE, software packages have been developed to simplify analysis of protein expression. One such example, DeCyder (Amersham Biosciences) includes Difference In-gel Analysis (DIA), DeCyder Batch Processor (BP) and DeCyder Biological Variation Analysis (BVA) modules. DIA is generally used for pair-wise comparisons of samples within a single gel, while BP and BVA allow protein expression to be quantified across multiple gels. BP and BVA thus provide an advanced level of analysis for identification of differentially expressed proteins between experimental groups containing many samples. We have recently employed 2-D DIGE coupled with BP/BVA to investigate protein expression changes in white and grey matter of the prefrontal cortex of 10 schizophrenia patients compared with controls (manuscript submitted). Here, we describe the use of 2-D DIGE and BVA for human postmortem brain investigations, and highlight the advantages and potential pitfalls of the current 2-D DIGE technology.
Experimental design
In order to obtain meaningful results from the study, it is essential to consider carefully the experimental design. With a study where the protein expression profile of individual biological samples is to be examined (e.g. samples from 10 individual schizophrenia patients and 10 controls), it is necessary to employ a method that can assess biological variation (to be confident that altered protein expression is disease-specific and not just a result of natural variation within a population) and minimise experimental variation. Both issues can be addressed using 2-D DIGE coupled with the recently introduced BP and BVA DeCyder modules. 2-D DIGE is not only a sensitive technique with a detection limit of between 100 and 200 pg of protein, 3 but the use of spectrally distinct fluorescent dyes (Cy2, Cy3 and Cy5) also allows for three samples to be run on the same gel simultaneously. This multiplexing is beneficial because it allows for an internal standard (labelled with Cy2) to be included in each gel alongside the individual samples under investigation (labelled with Cy3 and Cy5) 4 ( Table 1 ). The internal standard, consisting of an aliquot of all the samples to be used in the experiment, is crucial for assessment of both biological variation and experimental (gel to gel) variation. Figure 1 highlights the importance of the internal standard to account for experimental variation. If gels 1 and 2 shown in Figure 1a and b were analysed without an internal standard, it would be concluded that protein expression was increased in disease samples 1 and 2 compared with control samples 1 and 2. However, when analysed with the internal standard (which has been subjected to identical experimental conditions), it becomes apparent that the increases shown in disease samples 1 and 2 are due to experimental and not biological variation; protein expression in disease sample 1 has not changed and protein expression in disease sample 2 is actually decreased. Similarly, if gels 1 and 3 ( Figure 1a and c) were analysed without internal standard, it would be concluded that the highlighted protein is absent in the disease samples 3 and 4. However, when the internal standard is taken into consideration, it becomes apparent that this is not a disease-specific change, but due to experimental variation where the protein has not resolved on gel 3. By expressing the spot volume for each protein as a ratio of the spot volume from the internal standard, standardised relative ratios are generated and the accuracy of protein expression quantification is increased.
Variation in protein expression among individual biological samples is most effectively assessed using BP and BVA analysis packages (see section Image analysis). These softwares make use of the internal standard first for intra-gel co-detection (of samples and internal standard), and then for inter-gel matching of the internal standard across multiple gels to ensure that the same spots in each gel are compared. In this way, protein expression can be simultaneously quantified for all samples even though they have been run on different gels. Application of statistical tests in BVA to data generated from all samples contained within an experimental group ensures that any differentially expressed protein can be attributed to genuine changes across experimental groups rather than to natural variation alone.
Processing of samples with 2-D DIGE involves several steps and each needs to be optimised with respect to the tissue/sample used and approach employed. Important considerations for each stage are discussed below in detail, particularly with The internal standard consisting of an aliquot of all 40 samples used (10 schizophrenia white matter, 10 schizophrenia grey matter, 10 control white matter, 10 control grey matter) was labelled with Cy2 and run alongside individual samples labelled with either Cy3 or Cy5. The order in which samples were paired was not important for this study, except for ensuring that half the samples from each group were labelled with Cy3 and the other half were labelled with Cy5; this was to minimise potential dye artefacts. For each gel, Cy3-, Cy5-and Cy2-labelled proteins were mixed before separation over the same first and second dimension.
reference to human postmortem tissue. An overview of the steps involved for 2-D DIGE is shown in Figure 2 .
Preparation of human postmortem samples for 2-D DIGE
In order to use 2D-gels for analytical and quantification purposes, it is essential to obtain well-focused protein spots on gels. Since the quality of the final gels will be directly influenced by the quality of the starting material, it is important to acquire tissue for the study that has been carefully preserved to minimise degradation. The best indicator for highquality brain tissue is intact mRNA profiles, 5 but the protein quality should also be assessed by running the 'best' and 'worst' samples (with respect to RNA quality and postmortem interval) alongside each other to identify signs of degradation in the form of a skew towards low molecular weight spots. Naturally, samples should be additionally matched as best as possible for parameters such as age, race, sex, postmortem interval, agonal period and drug treatments, etc.
Prior to sample preparation, it is important to establish the experimental aims, as this will directly influence how the samples are to be prepared. In circumstances where previous literature reports are not available for the use of 2-D DIGE with a specific tissue/cell type (as was the case for human postmortem brain), it is best to examine the global protein expression profile and view as many proteins as possible. In this situation, samples should be prepared with minimal sample manipulation to avoid selective protein loss or skew (a frequent problem with fractionation procedures).
Cy3
Cy5 Cy2 Choice of lysis buffer and homogenisation of human brain tissue High-resolution protein focusing will only be achieved if the sample proteins are disaggregated and solubilised, thus all samples must be prepared in a lysis buffer containing denaturing and solubilising agents. Denaturing conditions are created by the addition of urea (8 M) , and solubilisation by the addition of one or more detergents. Owing to low solubility of membrane and hydrophobic proteins, it is often not possible to visualise these proteins on 2-D gels. Solubilisation of these proteins can be improved using a combination of triton X-100 (1%) and a stronger detergent, amido-sulpho betaine 14 (ASB14, 2%) in the lysis buffer. It is unlikely, however, that proteins containing several transmembrane domains will be visualised on 2-D gels even with the use of these more powerful detergents. 6 Since subsequent labelling of proteins with CyDyes is optimal at pH 8.5 (see section Labelling of proteins with fluorescent dyes), samples must be prepared in lysis buffer containing 20 mM Tris-base to ensure that the correct pH is maintained throughout.
Homogenisation of any tissue (including human postmortem brain) has the potential for degradation of proteins due to the release and activation of proteases. Unfortunately, proteolysis will greatly complicate the subsequent 2-D gel analysis. For example, the same protein appearing at multiple positions on a gel may be due to either protein degradation and the formation of protein fragments, or to post-translational modifications such as phosphorylation (often seen as a charge trail, see Figure 3 ) and/or different isotypes. It is therefore important to minimise protein degradation during sample preparation to avoid potential artefacts. The presence of the strong denaturing agent urea will, in most cases, provide sufficient protection against proteolysis, but protease inhibitor cocktail tablets (e.g. Roche Diagnostics) can also be included for increased confidence. Since protease activity is also reduced at lower temperatures, all samples should additionally be prepared on ice. One advantage of 2-D gels is the ability to visualise phosphorylation events as these result in a change in the isoelectric point (pI) of a protein. To help maintain the phosphorylation status of proteins, a number of phosphatase inhibitors can be added to the lysis buffer including sodium pyrophosphate (1 mM), sodium orthovanadate (1 mM), beta-glycerophosphate (10 mM) and sodium fluoride (50 mM).
An ideal lysis buffer for homogenisation of brain samples is 2% ASB14, 8 M urea, 5 mM magnesium acetate, 20 mM Tris-base pH 8.5, together with protease and phosphatase inhibitors. The efficiency of homogenisation can be improved by first cryostat sectioning from fresh-frozen tissue blocks (10 mm thick sections) to increase the surface area, and then homogenising the samples using a ribolyser (Thermohybaid; 3 Â 20 s, force 6.5). Many of the brain samples, particularly from grey matter, are quite viscous following homogenisation and difficult to pipette owing to the presence of significant amounts of DNA in the sample. This can be improved by adding magnesium acetate (5 mM) to the lysis buffer to reduce DNA aggregation.
Protein precipitation
In order to obtain well-resolved 2-D gels without introducing streaking/smearing, it is best to remove as many of the non-protein components as possible from the samples (e.g. nucleic acids and lipids). Proteins should therefore be extracted from samples, for example by precipitation using ammonium acetate (100 mM) in methanol, and then any lipids removed Figure 3 Post-translational modifications and/or isoforms are visible by 2-D GE. Protein extracted from human prefrontal cortex (100 mg) was labelled with Cy3 (400 pmol) and separated on a 24 cm pH 3-10 nonlinear IPG strip and 12% SDSpolyacrylamide gel. The gel image (a) was visualised by scanning for Cy3 fluorescence using a Typhoont 9400 scanner. The enlarged gel image (b) shows a charge trail of four protein spots characteristic of post-translational modifications such as phosphorylation and/or protein isoforms. The corresponding 3-D profile for spots 1-4 are shown in (c) and are generated from DeCyder BVA software. The amount of protein is proportional to the volume of the protein peak. using 80% acetone. DNAse/RNAse may be added to remove residual nucleic acids, but it is important to remember that because these enzymes are extremely soluble, they will also be resolved on subsequent 2-D gels depending on the parameters used for the first and second dimensions. Following precipitation, protein pellets should be resuspended in lysis buffer preferably without protease and phosphatase inhibitors (2% ASB14, 8 M urea, 5 mM magnesium acetate, 20 mM Tris, pH 8.5), and stored at either À201C (short term) or À801C (long term). Once urea has been added, the samples must not be heated above 371C, as elevated temperature results in the conversion of urea to isocyanate which modifies proteins by carbamylation of primary amines. This modification can lead to changes in the pI of the protein that influences how the protein focuses during the first dimension.
Determination of protein concentration
It is crucial to accurately quantify protein concentrations prior to electrophoresis to ensure that equivalent amounts of protein are compared between samples, and that fluorescent labelling is reproducible. Since the lysis buffer contains detergents that interfere with some protein assays, a detergentcompatible protein assay (Biorad DC Assay kit) should be used for protein quantification. Thiourea, which is required as a denaturing agent for the first dimension separation, interferes with this protein assay and so thiourea must be added at a later stage prior to electrophoresis (see the next section). If thiourea is included in the lysis buffer from the beginning, the protein concentration can be determined by use of a thiourea-tolerant protein assay kit (e.g. 2-D Quant Kit, Amersham Biosciences). Following determination of protein concentration, it is recommended that all samples are diluted appropriately using lysis buffer to give a 5 mg/ml solution before freezing in aliquots at either À201C or À801C. The amount of protein extracted from B150 mg wetweight human brain tissue by ammonium acetate/ methanol precipitation is B15 mg, which is more than sufficient material for 2-D DIGE studies.
Labelling of proteins with fluorescent dyes
In order to take advantage of the multiplexing potential of 2-D DIGE, samples must first be labelled with one of three CyDyes (Cy2, Cy3 or Cy5). These dyes are ideal for co-detection because each has a distinct emission wavelength that minimises crossdetection between them, and allows each dye to be independently imaged. Furthermore, CyDyes are water-soluble and their signal does not alter over a wide pH range, and thus the dye signal is not influenced by first dimension separation. Each CyDye has been chemically designed to incorporate an NHSester group that covalently attaches, via an amide linkage, to the epsilon amino group of lysine residues. At neutral and acidic pHs, lysine residues carry an intrinsic þ 1 charge which would be lost by reacting with the CyDyes. To ensure that the pI of the protein is maintained during labelling, therefore, CyDyes also carry a single positive charge. CyDyes are also sizematched such that coupling of one dye molecule to the protein adds approximately 500 Da. This is essential if proteins labelled with different CyDyes are to migrate to identical positions on the 2-D gel. The combination of charge-and size-matching of CyDyes ensures that the samples labelled with any fluor overlay exactly, and that subsequent comparison of protein expression is accurate.
For consistent labelling, it is important to control the amount of dye that reacts with proteins; labelling of proteins with variable numbers of dye molecules would result in the same protein having slightly different masses, and migration of these species to different positions on the gel which in turn would complicate subsequent analysis of 2-D gels and compromise protein quantification. This problem has been overcome with the development of the 'minimal labelling technique' by Ü nlü et al 1997 2 whereby each protein is labelled with a maximum of only one dye molecule. The high sensitivity of the CyDyes ensures that there are no problems with detection of the fluorescent signal. An optimal dye to protein ratio of 400 pmol dye per 50 mg protein is recommended for minimal labelling but for costeffectiveness, this ratio can be reduced (at least for human brain studies) such that 100 mg of protein is labelled with 400 pmol dye without compromising sensitivity.
The pH at which the labelling reactions are performed is also crucial to ensure consistent labelling, as the NHS ester reactive group of the CyDye fluors can only react with unprotonated amino groups of lysines. The pH of the reaction should therefore be set to ensure that there are suitable numbers of lysine residues with unprotonated ÀNH 2 groups. If the pH is too high, many ÀNH 2 groups will be unprotonated and thus many lysines will be labelled during the reaction, but if the pH falls too low, most ÀNH 2 groups become protonated and few lysines will be labelled. For minimal labelling, the optimal pH is 8.5, which can be maintained by 20 mM Tris base buffer.
Samples labelled with different CyDyes need to be mixed before first and second dimension separations, hence all unbound dye must first be quenched to stop the reaction and prevent cross-labelling. This is done by addition of lysine (50-fold excess). The labelled samples can then be pooled and prepared for first dimension separation by the addition of an equal volume of sample buffer (2% ASB14, 7 M urea, 2 M thiourea, 2% dithiothreitol (DTT) and 2% carrier ampholytes). The combination of detergents (ASB14) and denaturing agents (urea, thiourea and DTT) in the sample buffer is required to ensure that proteins are optimally solubilised and disaggregated for highresolution focusing in the first dimension. Carrier ampholytes, amphoteric molecules that are capable of high buffering capacity around their pI, are included in the sample buffer to enhance protein solubility. Addition of carrier ampholytes thus improves focusing of proteins in the first dimension by minimising protein aggregation, which would otherwise be caused by charge-charge interactions. Samples are then made up to a suitable volume (450 ml for 24 cm strips) with rehydration buffer (2% ASB14, 7 M urea, 2 M thiourea, 0.2% DTT and 1% carrier ampholytes) before first dimension separation. If samples are not run immediately, they can be stored before addition of rehydration buffer at À801C for several months. All incubations during the labelling procedure must be carried out in the dark to minimise any photobleaching of the fluorescent dyes.
First and second dimension separation of proteins
First dimension separation First dimension separation is based on the movement of electrically charged proteins along a pH gradient under the influence of an applied electric current. This technique, known as iso-electric focusing (IEF), is an electrophoretic method that separates proteins according to their unique pI. The pI of a protein is the pH at which the protein carries no net charge, and is essentially dependent upon the unique complement of acidic and basic amino-acid side-chains present in a protein sequence. When an electric current is applied across the pH gradient, charged proteins migrate to a position on the gradient equal to their pI resulting in 'focusing' of proteins, in that if a protein should diffuse away, it will immediately gain charge, and under the influence of the continued electric current, will revert back to the same position. Thus, it is possible to resolve proteins with even very small charge differences. High-resolution focusing is achieved firstly by the full solubilisation and disaggregation of proteins and secondly by performing IEF at high voltages (500-8000 V).
Generation of a stable pH gradient is crucial for reproducible IEF. Traditionally, pH gradients were created using carrier ampholytes in polyacrylamide tube gels. However, because these ampholytes are soluble, the pH gradients were unstable resulting in gel-gel variations. This problem has been ameliorated with the development of immobilised pH gradients (IPG), 7 whereby the acidic and basic buffering groups are covalently bound to acrylamide monomers. This led to a dramatic improvement in the reproducibility of first dimension separation. IPG strips are now commercially available in a variety of different lengths and pH ranges, and the experimental aims will determine which is the most suitable. To obtain an overview of protein expression while maintaining the highest possible resolution, it is best to use a long IPG strip of a wide pH range (e.g. 24 cm pH 3-10 nonlinear IPG strips as used in the current study). A given sample (in rehydration buffer) is pipetted into 24 cm ceramic strip holders (coffins) with in-built platinum electrodes, and overlaid with an IPG strip avoiding the introduction of air bubbles, which may interfere with the rehydration step. The entire length of the strip must be covered with IPG coverfluid to reduce evaporation of samples and prevent urea crystallisation. Coffins are then placed on an electrophoresis unit such as an IPGPhor (Amersham Biosciences) firstly for rehydration and warming (20 V for 10 h), and then for IEF using a ramping protocol (e.g. 500 V for 1 h, 1000 V for 1 h, 8000 V for 8 h, for 24 cm pH 3-10 NL strips). An internal cooling unit ensures that the heat generated by the high voltages used during IEF is not detrimental to the protein samples.
Following IEF, IPG strips can theoretically be stored at À201C for short time periods (a few weeks) before the second dimension is carried out. With separation of proteins from human postmortem tissue, we found that the best results were achieved when the second dimension was performed as soon as possible after IEF (preferably within a week).
Second dimension separation
Second dimension separation involves the use of sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) to resolve proteins according to their denatured molecular weight. SDS is an anionic detergent that disrupts secondary and tertiary structures of proteins. The intrinsic charge of proteins is masked, and negatively charged complexes proportional to the mass of each protein are formed. Proteins are completely unfolded using DTT to disrupt disulphide bonds, and the combination of this and SDS allows for separation to be based exclusively on molecular weight.
Samples may be separated in the second dimension using gels of a variety of different sizes, but 16 Â 14 cm gels (e.g. DIGE SE600) or larger 26 Â 20 cm format gels (e.g. DIGE Ettan DALT gels, Amersham Biosciences) are most commonly used. Separation of samples using large-format gels is advantageous because the resolution of the protein spots is much improved compared with the smaller gels ( Figure 4) . In all, 12% SDS-PAGE gels allow resolution of a wide range of molecular weight proteins (between 20 and 110 kDa, see Figure 9 ), but gradient gels may be used to separate an even wider molecular weight range of proteins if required. Gels should be manually cast at least 9 h (preferably left overnight) prior to use to enhance reproducibility of second dimension separation.
Before placing IPG strips onto pre-prepared polyacrylamide gels, strips are first incubated in equilibration buffer (30% glycerol, 8 M urea, 1% SDS, 0.5% DTT, 0.2 mg/ml bromophenol blue, 100 mM Tris pH 6.8) for 15 min and then rinsed in Tris/glycine/SDS running buffer. Any large air bubbles present between the IPG strip and gel must be removed prior to electrophoresis as bubbles hinder the movement of proteins from the strip into the second dimension gel. Strips are then overlaid with agarose containing bromophenol blue (to hold the strip in place, and to provide a dye front) before performing electrophoresis. To maximise the resolution of protein spots, large-format gels can be run slowly for B20 h at 2 W per gel.
Imaging
Once the samples have been separated in the second dimension, gels are scanned for Cy2, Cy3 and Cy5 fluorescence using an appropriate scanner such as the Typhoont 9400 imager (Amersham Biosciences). Cy2, Cy3 and Cy5 images can be scanned using 488, 532 and 633 nm lasers, respectively, and an emission filter of 520 nm (band pass 40), 580 nm (band pass 30) and 670 nm (band pass 30), respectively. The narrow band pass emission filters ensures that there is negligible crosstalk between fluorescent channels. Prior to the final scan, all gel images should be prescanned at 1000 mm resolution to choose the appropriate photomultiplier tube voltages (PMT) for each channel. The PMT voltage can then be adjusted for each channel to ensure that the image intensity is within a linear range between 40 000 and 80 000 U. It is essential to choose an appropriate PMT value for each channel as spot intensities should neither reach saturation (100 000 U) nor go below the linear scale during the final high-resolution scan (100 mm). It is particularly important to avoid saturation because spots with a spot intensity of 4100 000 U cannot be quantified. It is advisable, therefore, to check all gel Figure 4 Large format DIGE Ettan DALT gels provide better resolution for human postmortem brain samples than DIGE SE600 gels. Protein extracted from human prefrontal cortex (100 mg) was labelled with Cy5 (400 pmol) before separation over first dimension using 13 cm IPG strips, pH 3-10 (a) or 24 cm IPG strips, pH 3-10 nonlinear (b). Samples were further separated by SDS-PAGE (12%) using DIGE SE600 gels (16 Â 14 cm) (a), or the large format DIGE Ettan DALT gels (26 Â 20 cm) (b). Gels were scanned for Cy5 fluorescence using Typhoont 9400.
images individually for spot saturation (e.g. using ImageQuant, Amersham Biosciences). If spots are shown to be saturated, gels can then be re-scanned with a reduced PMT value in the appropriate channel/s. Since the protein spots have a propensity to diffuse, all gels should be scanned as soon as possible, preferably on the same day, to ensure optimal focusing.
Image analysis
Image analysis has been greatly improved with the introduction of automated software packages that allow quantification of protein expression with reduced user intervention and/or bias. Automation of analysis has the additional advantage of reducing user-variability, thus improving the reproducibility of results obtained from such investigations. 2-D DIGE coupled with DeCyder DIA or the equivalent has generally been used for quantification of protein expression. [8] [9] [10] [11] However, there are a number of disadvantages of using DIA with a study requiring analysis of individual biological samples. The primary limitation of DIA is that the software only allows for single pair-wise comparisons. With individual samples, where protein expression is likely to vary, the same protein may hence be seen by DIA to be significantly increased, decreased or not changed depending on the pair of samples chosen ( Figure 5 ).
Pair-wise comparisons for large-scale studies are also labour-and cost-intensive, because each control sample should ideally be compared against each disease sample. In the case of 10 control and 10 disease samples for example, this would require 100 gels to be run for complete analysis. The way that DIA identifies significant changes in the volume ratios of spots between experimental groups can also be a problem with DIA. Since DIA only generates a single volume ratio for each protein from a pair-wise comparison, there is insufficient data for application of statistical tests. Significant changes in DIA are therefore identified by means of a threshold value. This value is determined experimentally by pair-wise comparisons of 'same vs same' and is designed to take into consideration experimental noise. For a samesame comparison, the log volume ratios should equal zero and thus any deviations from this indicate experimental noise. For a change to be significant, therefore, it is important to set an appropriate threshold to ensure that volume ratio changes are unlikely to have occurred by chance. This value should be determined for each type of sample, but for human postmortem brain, the threshold value for volume ratios should be set to at least 1.5-fold (log volume 0.18) ( Figure 6 ). This is not a problem for pairs of samples where protein changes are likely to be large (greater than the threshold), but in the case of schizophrenia vs control samples at least, changes in protein expression were often small (o1.5-fold). For our schizophrenia study, the experimental noise was therefore greater than the protein expression changes required to be seen and false negative results would be generated. A further problem with DIA is the inability for the software to analyse the data generated by all gels for group statistical analysis. Although the data for each protein spot is available in DIA, each data point would have to be manually extracted from the software for further statistical analysis. Not only would this be time consuming, but errors could also be introduced because complete manual matching of protein spots across gels would be necessary.
The analysis problems associated with DIA can be addressed using DeCyder BP and BVA. These softwares are particularly useful for analysing data obtained from individual biological samples because, through the use of an internal standard, they allow processing of multiple gel images, quantification of protein expression of all individual biological samples included in the experiment and statistical analysis of group data. Furthermore, the number of gels required for a complete study in BVA is much reduced compared with that required for DIA. In the example of 10 control and 10 disease samples, only 20 gels are required for BVA analysis (Table 1) compared to 100 gels that would be required for a DIA approach.
Generally, before gel images can be imported into BVA, they must first be cropped to remove areas extraneous to those of interest. It is essential to identically crop Cy2, Cy3 and Cy5 images within the same gel to allow subsequent co-detection of Pair-wise comparison of protein expression is not suitable for quantification of protein expression using individual biological samples. The standardised log abundance (sample: internal standard) generated by BVA for 10 control (J) and 10 schizophrenia (K) samples are shown for a single protein spot. Depending on the pairing of control samples with schizophrenia samples, the observed protein expression is increased (pair 1), decreased (pair 3) or unchanged (pair 2) in schizophrenia compared to control. By investigating all control and schizophrenia samples simultaneously in BVA, it is apparent that the protein expression is overall decreased in schizophrenia compared with control.
spots, and this may be done using ImageQuant Tools (Amersham Biosciences). Cropping of images is necessary because the analysis software will attempt to quantify everything present in the gel image, which can skew the normalisation and reduce the number of 'real' protein spots detected. In addition, it is best to crop images to a similar extent as this helps spot matching across individual gels. Having cropped images appropriately, they are then analysed using BP. This software provides a link between DeCyder DIA (Amersham Biosciences), which performs intragel analysis, and BVA, which performs inter-gel analysis. Using a co-detection algorithm, BP firstly performs intra-gel spot detection between pairs of images (Cy3 and Cy2, and Cy5 and Cy2). The multiplexing design of 2-D DIGE ensures that identical spot boundaries are defined for each scanned image. Before spot detection, the user should estimate the number of expected spots that should be optimised for the size of gel, pH strip and the type of sample used. If the number is too high, one protein spot may be split into two or more parts, but if the number is too low, spots may be missed and data points could be lost. This is a particular problem if the images have not been cropped sufficiently and spot numbers are wasted trying to quantify extraneous regions of the gel image. For human postmortem brain (used in conjunction with 24 cm pH 3-10 strips and large format gels), the number of spots should be estimated at 2500, since the average number of spots identified by BP/BVA is routinely 2045. Individual protein spots are then quantified based on their pixel intensities. Data concerning the spot volume (with background subtracted), area, peak height and slope are collected for each spot, and then standardised abundance ratios are calculated for each pair of images (Cy3 : Cy2, and Cy5 : Cy2). These ratios are normalised to correct for differences in dye intensities. BP then prepares the data for importing into BVA; each sample is marked with a group identifier, and initial inter-gel spot matching is performed. One gel within the experiment must be assigned as the master gel. Unless otherwise stipulated, the gel image with the most spots identified is automatically assigned by the software as the master gel. In some cases, it may be more appropriate to assign a master gel manually to ensure that a well-focused gel is chosen for more effective intra-gel matching. All other gel images are then matched against this master gel using a pattern-recognition algorithm. The main advantage of BP is that it provides a means to automation, as once the processor has been set up, all gel images included in the study are processed sequentially without user intervention and/or bias.
With a large-scale study, this inevitably saves time. Once gel images have been processed by BP, they are then imported into BVA for user assessment. The initial spot matching carried out by BP must be carefully checked to ensure that the same protein spots are compared across all gels, as this will influence the validity of the subsequent statistical analysis. Gel images must therefore be examined for precision of spot matching against the master gel. It is only necessary to check the matching of Cy2 images to the master image as spots on corresponding Cy3 and Cy5 images will be identically positioned. The accuracy of matching will depend on the quality of the gels. If proteins are not well focused or there is horizontal/vertical streaking, matching is generally poor, and it is often best to discard such gels from the analysis to avoid potential skewing of data. For gel images that are of sufficient quality to be included in the analysis, it is important to 'landmark'. Landmarking is a feature of BVA that allows the manual matching of spots; correct matches can be confirmed, and incorrect matches may be broken and replaced with correct matches. The number of spots that should be confirmed depends on how well the gel image has been matched to the master image; more spots should be confirmed for gels that are not well Figure 6 Data histogram to determine threshold of significance in DeCyder DIA. The same human prefrontal cortex brain sample was labelled with Cy3 or Cy5 and mixed before separation over the same first and second dimensions. The gel was scanned for Cy3 or Cy5 fluorescence and the gel images imported into DeCyder DIA software for analysis. The spot volume for each protein was calculated for both Cy3 and Cy5 images using the standard spot detection algorithm and a spot volume ratio was calculated. A data histogram was generated by plotting spot frequency against log volume ratio and a normal distribution (model histogram) was fitted to the main peak of the frequency histogram. The data was then normalised and the model peak of the model histogram was shifted so that the log volume ratio for the majority of spots was equal to zero. The modified ratio values were then combined to form a normalised data histogram. The data histogram and model histogram are shown by the red and blue lines, respectively. In all, 93% of protein spots ( ) are contained within a 0.176 log volume ratio threshold shown by the solid black lines. Only spots of very low volume (o4 Â 10 5 pixels) are excluded ( )( ) (7% of the total). matched. These confirmed spots are then used by BVA to re-match all protein spots to the master image. Although this step is time consuming, it is worth the invested effort because the accuracy of matching and the quality of data is always improved.
Having accurately matched protein spots across gels, statistical analysis can then be applied. Two statistical tests are available within BVA, a Student's t-test for comparisons between two groups, and an analysis of variation (ANOVA) for comparisons across many groups. Using data generated from all the gel images for a single protein spot, a statistical probability value (p-value) is assigned using the appropriate statistical test. This gives a probability value on whether the data arises from groups that are the same; a low p-value indicates that protein expression is altered between experimental groups. Data with a probability value of po0.05 has a 95% confidence that a change has not arisen by random chance and is generally accepted as indicating statistical significance, but in a situation where many hundred protein spots are subjected to statistical analysis (as in the case of 2-D gel analysis), po0.01 can be used to reduce the number of false positives. All spots identified as significantly altered between experimental groups should be individually assessed to confirm that the spots are 'real'. Criteria such as the 3-D spot profile, the spot volume, and whether the spot is present on the majority of gel images can be used to help decide if a protein spot should be confirmed.
The 3-D spot profile provides a clear distinction between artefacts such as dust particles and genuine protein spots; dust particles will have a sharp 3-D profile with a pointed peak (Figure 7a ) compared with the smoothers curve of a protein spot (Figure 7b ). More ambiguous spots with a profile similar to that shown in Figure 7c are more difficult to verify and require user discretion to decide if these are real spots or not. In most of these cases, the spot volume would be too low for successful protein identification by mass spectrometry. Generally, spot volumes of o4.5 Â 10 4 will not contain sufficient protein material to generate LC/MS/MS data, but this volume threshold should ideally be optimised for sample and the type of mass spectrometer used. The data output from BVA can also help decide if a spot should be confirmed; a spot present in the majority of gels (Figure 7d ) is more likely to represent a genuine spot compared with a spot that is missing in many of the gels (Figure 7e ).
Excision of protein spots for identification
Once protein spots of interest have been established using BVA, the next stage is to identify differentially expressed proteins by sequencing. In order to maximise the success rate of protein sequencing it is best to pick spots of interest from a 'preparative' gel where an excess amount of protein has been loaded. The maximal amount of protein that can be loaded onto Figure 7 Confirmation of genuine protein spots in BVA. The 3-D spot profile generated by BVA allows a dust particle (a) to be distinguished from a genuine protein spot (b). Spots with 3-D profiles similar to (c) require more consideration and user discretion to establish whether these should be confirmed as genuine spots. The data shown in (d) is an example of the data output from a genuine protein spot in BVA. Each data point represents the standardised log abundance (sample: internal standard) of a protein spot obtained for each of the 10 schizophrenia grey matter samples ( , group 1), control grey matter samples ( , group 2), schizophrenia white matter samples ( , group 3) and control white matter samples ( , group 4). Spots present in the majority of gels included in the experiment (d) are more likely to represent genuine protein spots compared with spots present in only a few gels (e). large format gels (without reducing the quality of protein focusing or causing streaking) is B400 mg. For the preparative gel, it is best to use a sample from the pooled internal standard to ensure that all spots that potentially need to be picked are indeed present on the gel.
Once first and second dimensions of the preparative gel have been run under identical conditions to those used for the analytical gels, the gel can then be fixed overnight (acetic acid, 1%/methanol, 45%) to prevent protein diffusion, and then post-stained to visualise the proteins. For manual spot picking, Colloidal Coomassie Brilliant Blue (30-100 ng detection limit) 12 is commonly used. SYPRO Ruby stain (molecular probes), a more sensitive fluorescencebased stain (detection limit 0.25-1 ng), 13 can also be used in conjunction with an automated spot picker where spot co-ordinates imported from DeCyder determine the pick position. The stained preparative gel should first be scanned to identify proteins of interest before appropriate spots are excised from the gel for sequencing.
Mass spectrometry
Once a set of protein spots from a 2D-DIGE or standard 2D PAGE gel has been excised, the next step is proteolytic digestion. This procedure is easily automated by robotics that primarily reduces preparation time, but also (importantly) minimises contamination by keratins from hair, skin, dust and clothing. Excised spots must be de-stained, depending on the visualisation method used, reduced and alkylated to prevent interpeptide disulphide bridge formation which could complicate analysis, and finally digested into relatively short peptides using a robust protease. The protease most frequently employed is trypsin, which cleaves the peptide bond at the C-terminal side of lysine and arginine residues. In the case of 2D-DIGE, the minimal labelling results in only B3% of lysine residues being modified and therefore does not significantly reduce the number of available tryptic sites. Peptides generated are extracted in an appropriate solvent compatible with the mass spectrometric technique to be used.
There are two different mass spectrometric techniques that are typically employed for the identification of proteins by analysis of peptide fragments. These differ primarily in the method of ionisation of peptide species. The first method is matrix assisted laser desorption ionisation time of flight mass spectrometry (MALDI-TOF MS) 14 and the second is nanospray tandem mass spectrometry (nanospray/LC-MS/ MS). [15] [16] [17] These two techniques have complementary strengths and weaknesses when used in conjunction with human brain proteins resolved by 2D PAGE methods as discussed below.
MALDI-TOF mass spectrometry
With this technique, peptides produced from in-gel digestion are co-precipitated with an organic matrix (typically alpha-cyano-4-cinnamic acid) on a metal sample plate. Ions are generated through the use of a laser (usually nitrogen) which is fired at the sample. The mass/charge ratio of the resulting ions formed are simultaneously analysed to produce peptide mass fingerprints which are then matched against protein databases in order to identify the corresponding proteins. [18] [19] [20] [21] This high throughput technique is relatively inexpensive. There are occasions, however, when peptide mass fingerprinting alone is not sufficient for identification because either the correct protein sequence does not appear in a database or, more commonly in the case of complex samples such as unfractionated human brain tissue, the map represents a mixture of proteins.
Nanospray ionisation mass spectrometry (nano-ES)
In cases where MALDI-TOF MS fails to give identifications and/or studies where the quality of data is of paramount importance, nanospray/LC-MS/MS is the preferred technology. In this technique, peptides are separated by reverse phase chromatography using a low flow rate HPLC that is coupled to a tandem mass spectrometer, a mass spectrometer containing mass analysers in series (MS/MS). The ions are formed during the process of spraying peptides into the mass spectrometer from the HPLC outlet in the presence of an organic solvent at high voltage. Individual ions (precursor ions) are then selected in the first mass analyser and introduced into a collision cell within the mass spectrometer, which contains an inert gas such as argon. The precursor ions are bombarded by this collision gas which causes them to fragment typically at the peptide bond. The fragment ions are then analysed by the second mass analyser, which is usually a time-of-flight analyser. In this way an MS-MS spectrum is produced of the fragment ions that arise directly from the chosen precursor ions for a given peptide component. Sequence information from the fragmentation of each peptide taken as a precursor ion can then be interpreted (see Figure 8d) . Generally, however, 'uninterpreted' fragmentation data (MS/MS data) from all peptides generated from a single excised spot are submitted to powerful search engines such as MASCOT (Matrix Science Ltd.). Such programmes compare databases of peptide sequences and their theoretical fragmentation patterns with a given MS/MS spectrum. The advantages of this method over peptide mass fingerprinting are (1) mixtures of peptides can be identified and (2) if no sequence is obtained from a database search using uninterpreted fragmentation data, the peptide sequence can be deduced de novo and used in a BLAST search. The data typically obtained from MASCOT search engine is shown in Figure 8 .
Data management
The mass spectrometry data submitted to MASCOT is generally used to search the National Centre for Biotechnology Information (NCBI) primary sequence database for protein identification. Although there are many protein databases available for searching within MASCOT, NCBI is a good choice because it is the most comprehensive and is most frequently updated with new protein sequences. The disadvantage of using this database, particularly for human searches, is that there are many redundant entries. As a result, the searches invariably generate multiple positive identifications for the same protein. With so many identification codes (Gi numbers) per protein spot, it can be difficult to establish whether these relate to a specific protein isoform. This can cause problems in establishing an appropriate means for the data to be presented for publication. For example, it may be impractical to list all Gi numbers obtained from each protein spot because in excess of 30 different identification numbers can be listed for some proteins in some instances. However, it is also important not to give misleading information by listing a single Gi number which does not represent all relevant protein Figure 8 Identification of protein by LC/MS/MS and protein database searches. Sequence information obtained from Nanospray/LC/MS/MS of a single excised protein spot was taken and submitted to MASCOT (Matrix Science Ltd.) search engine for protein identification using the National Centre for Biotechnology Information (NCBI) protein database. The MASCOT results file (a) lists all entries from the NCBI protein database for known protein sequences matching the experimental peptide sequence data (in this case enolase). MASCOT has an intrinsic statistical analysis package that allows each entry to be assigned a probability score for the match. Total scores of 451 indicate extensive identity or homology (po0.05). This is graphically represented within the MASCOT results file (b). The mass, total probability score, number of peptides matched and details associated with the matched peptides is also shown (c). The raw data file obtained from Nanospray/LC/MS/MS and MassLynx v.3.5 for the peptide fragment identified as YISPDQLADLYK (underlined in (c)) was used for manual sequencing using the BioLynx feature of MassLynx (d). A BLAST search showed that this sequence is consistent with human enolase.
isoforms. To overcome this problem, manual searches of protein databases can be made; first of all with the NCBI database to establish the correct name/isoform associated with each Gi number, and then with nonredundant Swiss-Prot/TrEMBL database searches (http://us.exPASy.org/sprot/) to obtain a unique identification code. Although this is time consuming, several Gi codes can be reduced to one Swiss-Prot or TrEMBL identification code, which is easier to report and is more widely used and accepted.
Results from the human schizophrenia brain study To investigate changes in protein expression associated with schizophrenia, 10 prefrontal cortex samples from schizophrenia individuals and matched Protein profiling of human postmortem brain using 2-D DIGE JE Swatton et al controls were processed as described in the previous sections. DeCyder BP and BVA identified an average of 2043 spots from human postmortem brain samples using 2-D DIGE. Of these, B1256 were successfully matched across all 20 gels and then quantified. Those that were identified as being significantly altered between experimental groups as determined by a Student's t-test (215 protein spots, po0.05) were excised from the preparative gel for sequencing by LC/MS/MS. Of all the protein spots sequenced, 79% gave positive protein identifications, and of these 72% contained proteins of a single identity. Proteins identified from the current 2-D DIGE human study were primarily those associated with metabolism/ cellular respiration, axonal/neuronal growth, protein trafficking/turnover, cellular signalling and the cytoskeleton. Figures 3, 4b and 9 show the typical pattern of protein spots observed when proteins are separated over 24 cm pH 3-10 NL strips and 12% SDS-PAGE. The identification and localisation of proteins sequenced in our study is also highlighted in Figure 9 . It is interesting to note that there were marked differences in levels of protein expression between Figure 9 Spot identification and localisation of proteins from human brain on a 2-D gel. Proteins extracted from human prefrontal cortex (400 mg) were separated using 24 cm nonlinear pH 3-10 strips and 12% SDS-PAGE. Proteins were excised from the gel and sequenced by Nanospray/LC/MS/MS. white and grey matter. When grey matter control samples were directly compared with control samples from white matter, 122 protein spots were identified as being significantly upregulated in grey matter compared with white, and 111 protein spots were significantly downregulated (pr0.05). These differences probably reflect the anatomical as well as functional differences between these two tissue types of human brain.
Further studies and improvements for protein profiling of human postmortem brain Although 2-D DIGE and its associated analysis packages have many advantages for the high-throughput global quantification of protein expression, it is important to acknowledge the limitations of this technology. For example, with 2-D gels it is only possible to visualise the most abundantly expressed proteins whose solubility is sufficiently high; 3 data concerning all low abundant proteins and those which contain more than one transmembrane domain are likely to be missing. It may be necessary, therefore, to combine 2-D DIGE with other non gel-based proteomic techniques (e.g. isotope coded affinity tag, ICAT) 22 to enable additional protein complements to be analysed, depending on the aims of the experiment.
In terms of 2-D DIGE itself, there are a number of further experiments that can be undertaken to gain additional proteomic data to that of the current study, particularly in terms of improving the resolution of co-migrant proteins and those of lower abundance. Co-migration of proteins was an inevitable problem in this study primarily because the samples that we used were unfractionated. Accurate quantification of these mixture spots was consequently confounded because it was not possible to ascertain which of the proteins within the mixture was altered in expression, and some data (potentially important) from the study was lost. To improve this, samples could firstly be prefractionated, for example into cytoplasmic, plasma membrane, mitochondrial, lysosomal and ER/Golgi fractions, in order to simplify their protein content and increase the probability of resolving individual proteins. [23] [24] [25] [26] Prefractionation has the additional advantage of allowing increased amounts of protein to be loaded onto the gel, thus facilitating the detection of lower abundant proteins. 27 In addition, the study could be repeated using narrow-range IPG strips (zoom strips), for example over just one or two pH units to improve resolution of individual proteins. Zoom strips also improve the resolution of lower abundance proteins. This has been demonstrated with single unit pH zoom strips where as low as 300 protein copies per cell were successfully detected. 28 A combination of prefractionation and the use of zoom strips would therefore increase the chances of resolving mixtures and visualising the lower abundant proteins, while simplifying analysis and protein identification.
Ideally, all proteins identified as being significantly altered between experimental groups using 2-D technology should be cross-validated using other proteomic techniques, for example by Western blotting. With a large screening study such as this where many changes are identified, it is a difficult task to cross-validate all findings as antibodies may not be available for testing, but cross-validation of all important findings should be carried out wherever possible to minimise the potential of false positive results.
One limitation of 2-D gels is that relatively large amounts of tissue are generally required for experimentation. This can be a particular problem for postmortem tissue where the availability of tissue may be limited. With the recent introduction of the 'saturation labelling kit' by Amersham Biosciences, however, it is now possible to label as little as 5 mg of protein with CyDyes in for 2-D DIGE processing.
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Cy3 and Cy5 (but not Cy2 as of yet) have been developed such that they label all available cysteine residues under the conditions used, and as a result, the majority of proteins in the sample are labelled. This saturation labelling kit overcomes the need for large amounts of tissue and allows DIGE analysis to be applied to scarce or precious samples where it may not have been otherwise possible.
Conclusions
2-D DIGE has already been employed for examining the protein profiles of various tissues and cell types including those from bacteria, 4, 12, 30 mouse liver, 8, 31 metaplasia/cancer cells 9, 10, 32, 33 and adult cat/kitten brain, 34 but few studies 4, 12, 30, 33 have thus far utilised the recently introduced DeCyder BVA for quantification and analysis of protein expression. Here, we have described how 2-D DIGE may be successfully applied to human postmortem brain investigations, and how, in conjunction with BP and BVA, protein expression may be accurately quantified across individual biological samples. Furthermore, we have demonstrated that BVA is the preferred method for analysis of protein expression from individual biological samples compared with DIA alone.
2-D GE, particularly with the recent advances that have been made in 2-D DIGE and its analysis, is likely to remain the preferred technique for high throughput protein profiling of samples for some time to come. Coupling of 2-D DIGE with transcriptomic, metabolomic and non gel-based proteomic techniques will allow the exploration of pathological mechanisms associated with human disease to be investigated at the protein level, and may lead to new therapeutic and diagnostic possibilities.
